Daniël Lizarazo Fuentes - eToro Popular Investor

Daniël Lizarazo Fuentes @Etypsyno

Performance
0% Return
All

2026

2025

2024

2023

2022

2021

18.7%0%-18.7%

Return YTD 4.56%

Return 2Y 29.56%

Avg. Risk Score (last 7D)

Profitable Weeks 60.38%

Discussions

Daniël Lizarazo Fuentes

Netherlands

📊 Portfolio Update This year has been challenging for my portfolio, with overall performance under expectations. While the drawdowns have been lower compared to broader markets, the recovery has also lagged. Main drivers of underperformance: - Sylvamo: Increased maintance and very uncertain demand... Show More

Daniël Lizarazo Fuentes

Netherlands

UMG had a strong start to 2025, with Q1 revenue increasing by 11.8% year-over-year, driven by robust growth in recorded music and music publishing segments. EBITDA similarly also increased double digits by 23.1% (adj. EBITDA by 11.8%). Streaming came in quite low due to mix, i.e. margins on long form... Show More

Daniël Lizarazo Fuentes

Netherlands

10m

Despite the large drops we are seeing now history tells us that panicking now would be detrimental to your long term investing journey. When you invest broadly in the stock market for extended periods, the odds of positive returns dramatically increase with your time horizon. The S&P 500 has delivered... Show More

Daniël Lizarazo Fuentes

Netherlands

10m

𝐋𝐢𝐟𝐞𝐜𝐲𝐜𝐥𝐞 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 As a young investor, time is your greatest asset. I have more than 40 years of investment compounding remaining which is why I have done ample research into what are decent strategies to follow, at least academically,... Show More

Daniël Lizarazo Fuentes

Netherlands

11m

𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝘂𝗽𝗱𝗮𝘁𝗲 Over the last couple of months markets have become more uncertain about the future, mostly causes by politics and resulting economic uncertainty. This changes nothing in my strategy which is to buy and hold attractively priced and strong with lower market correlations.... Show More

Daniël Lizarazo Fuentes

Netherlands

𝗲𝗧𝗼𝗿𝗼 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗺𝘆 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗼𝗻 𝗨𝗠𝗚 Yesterday eToro published my article on $UMG.NV (Universal Music Group N.V), it could be an interesting read for you if you're considering diversifying into European growth equities. I go over UMGs position in the industry, the valuation... Show More

UMG.NV

Universal Music Group N.V

19.720

0.055 (0.28%)

Daniël Lizarazo Fuentes

Netherlands

𝐖𝐡𝐲 𝐓𝐞𝐜𝐡 𝐒𝐭𝐨𝐜𝐤𝐬 𝐃𝐫𝐨𝐩𝐩𝐞𝐝 𝐀𝐟𝐭𝐞𝐫 𝐃𝐞𝐞𝐩𝐒𝐞𝐞𝐤-𝐑𝟏’𝐬 𝐏𝐚𝐩𝐞𝐫 Tech stocks, especially in AI and semiconductors, fell after DeepSeek-R1’s release due to its reinforcement learning based training approach, which reduces reliance on massive datasets and computing power. The... Show More

Daniël Lizarazo Fuentes

Netherlands

𝐑𝐞𝐧𝐞𝐰𝐢 𝐫𝐞𝐚𝐜𝐡𝐞𝐬 𝐩𝐫𝐞𝐥𝐢𝐦𝐢𝐧𝐚𝐫𝐲 𝐚𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 𝐨𝐧 𝐚 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐚𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧 Last Thursday Renewi published a filing telling investors that together with Macquarie it had reached a preliminary agreement of 870 pence per Renewi share where Macquarie would acquire... Show More

Daniël Lizarazo Fuentes

Netherlands

𝗙𝗗𝗔 𝗮𝗽𝗽𝗿𝗼𝘃𝗲𝘀 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯'𝘀 𝗖𝗼𝗯𝗲𝗻𝗳𝘆 Last week Thursday the FDA announced it had approved Cobenfy (xanomeline and trospium chloride) as an oral medication for the treatment of schizophrenia in adults. It is the first new class of medicine (muscarinic agonist)... Show More

BMY

Bristol-Myers Squibb Co

61.86

2.47 (4.15%)

Daniël Lizarazo Fuentes

Netherlands

𝐖𝐡𝐲 𝐭𝐡𝐞 𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐝𝐨𝐰𝐧 𝐭𝐨𝐝𝐚𝐲 It's not often we see large indices like the Nikkei 225 drop more than 10% in a single day, let alone the decline from its peak last month which comes in at a 25.50% decline. The reasoning is very similar to other black swan events, in hindsight... Show More